Periventricular Leukomalacia Clinical Trial
Official title:
Telerehabilitation of Working Memory in Children With Periventricular Leukomalacia and Bilateral Cerebral Palsy, a Neuropsychological and Electrophysiological (High-density EEG) Study
Periventricular Leukomalacia (PVL) is a white matter lesion surrounding the lateral
ventricles of the brain occurring in the prenatal period, associated with a disorder of
movement and posture, known as bilateral cerebral palsy. Children with PVL and bilateral
cerebral palsy have spared verbal abilities, as measured by verbal Intelligence Quotient
(verbal IQ) tests, while non-verbal intelligence and especially visuo-perceptual and
visuo-spatial abilities are impaired. In addition some studies underline the impact of PVL
also on executive function, especially in terms of working memory and in the ability to
inhibit distraction.
Working Memory is the ability to retain and manipulate information for brief periods of
time. It is important in several complex cognitive functions, such as academic learning and
in planning and organizing daily life activities. School-based activities, indeed, such as
math and reading depend on a student's ability to pay attention to several instructions or
information and to hold and integrate them in their mind.
Recent behavioural and neurofunctional studies describes the effect of an evidence-based and
computer-based training on working memory, the Cogmed Working MemoryTraining. Functional MRI
show increase in parietal and prefrontal activity after this training, while the behavioural
data demonstrate the generalization of this effect also on cognitive functions not directly
trained, as attention, inhibition, learning and non-verbal reasoning. Cogmed Working
MemoryTraining (RoboMemo®, CogMed-Cognitive Medical Systems, Stockholm, Sweden) is an online
treatment comprising a number of visuo-spatial and verbal exercises that vary automatically
depending on the individual child's performance in any given task. The training period is
intensive and includes 25 home session for five weeks, 30-45 minutes each day. A
Cogmed-trained coach monitors training progress and participants' commitment daily.
Only one ongoing study has used the CogMed training in children with cerebral palsy, but
without investigating the correlation between behavioural findings with neurofunctional
data.
The aim of this study is to analyze the effect of the working memory training with CogMed on
trained and not directly trained cognitive abilities and on the changes in cortical
electrophysiological reorganization during the sleep after training. The sleep analysis will
be focused in particular on the slow waves activity [frequency range of 1-4.5 Hz] and on the
sleep spindle [frequency range of 12-14Hz], which reflect the depth of sleep and are related
to memory processes, learning and brain plasticity.
The results of this project will shed light on the mechanisms of neuroplasticity, by
enhancing knowledge on the neuropsychological effects of a specific working memory training
and on the neurophysiological underpinnings of these behavioural effects in a clinical
population of children with congenital brain lesions, as PVL.
The procedures implemented to register patients data will include the following steps:
- The quality assurance plan will provide: - to verify that all clinical fields,
necessary to include and select patients, are available in the registry (e.g. type of
cerebral palsy; MRI documentation, age); - to monitor that patients' contact
information are available as well as testing materials and software; - to set team
meetings to uniform recruitment procedure, data collection and registration.
- Data checks will be conducted by two or more researches from the team;
- Source data verification: both paper and electronic case report forms will be used and
mutually checked.
- Data dictionary: Pre-post measures will be chosen by the team and described in a report
form together with references and normative data.
- Procedure Standardization to address registry operations: Researches will co-work in
patient recruitment and will attribute an identification number to each patient
enrolled according to the inclusion and exclusion criteria evaluated by the
neuropsychiatric team and described below. All researchers will be trained to register
data in an internal database and to note the presence of adverse events. The researcher
providing the training will assure comprehension and subscription of the written
consent. Consent form will be discussed by the team in order to provide explicit and
clear instructions on the training protocol to parents and patients.
- Calculation of sample size: Sample size, to specify the number of participants
necessary to demonstrate the training effect, will be calculated from the training
effect size between the Start index and the Max index provided by CogMed training.
Based on a previous pilot study in our institute (effect size =.54) and on findings by
Lundqvist and collaborators (2010) (effect size=.95), the effect size estimates for
this study will be .60 and the sample size 20 children.
- Design: A stepped randomized clinical trial design will be chose to split the
participants in two groups, matching for age and sex, in order to control test-retest
effects. Both groups will receive neuropsychological and electrophysiological
assessments at the same initial time point (T1). One group (Cluster B) will be start
Cogmed training at home immediately after T1, while the second group (Cluster A) will
start the training in the following time point (T2). When the training will be
completed, both groups will be retested with neuropsychological and
electrophysiological assessments (T2). After this time point, the Cluster A will start
Cogmed training and will be re-tested with the same neuropsychological and the
electrophysiological assessments at the finally time points (T3).
- The following time points will be provided:
Initial time point (T1) will correspond to pre-training assessment for both Clusters; Second
time point (T2) will be provided after 6 or 7 weeks from T1 and will coincide with
post-training assessment for the Cluster B and an other pre-training assessment for the
Cluster A; Finally time point (T3), after 6 or 7 weeks from T2, will constitute the
post-training assessment for Cluster A.
- Intervention program: Cogmed Working MemoryTraining (RoboMemo®, CogMed-Cognitive
Medical Systems, Stockholm, Sweden) is an online treatment comprising a number of
visuo-spatial and verbal exercises that vary automatically depending on the individual
child's performance in any given task. The training period is intensive and includes 25
home session for five weeks, 30-45 minutes each day. A Cogmed-trained coach monitors
training progress and participants' commitment daily for all the training period,
corresponding to time period T1-T2 for Cluster B and T2-T3 for Cluster A.
- Plan for Missing data: Unavailable or not interpretable (significantly out of range)
pre-post training data (behavioural or neurophysiological) will be considered as
missing. The patients who will not complete the training will be excluded from the
analysis.
- Plan for Statistical analysis: Univariate and Multivariate statistical analysis will be
performed to compare neuropsychological performance and electrophysiological patterns
at the different time points . Correlational analysis will be also performed to study
the association between neuropsychological and electrophysiological data.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Completed |
NCT00375908 -
Umbilical Cord Blood Proteomic Analysis and Neonatal Brain Injury
|
N/A | |
Active, not recruiting |
NCT00515281 -
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
|
Phase 2/Phase 3 | |
Completed |
NCT03635775 -
Single-session tDCS in Cerebral Palsy
|
N/A | |
Active, not recruiting |
NCT04873752 -
A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy
|
Phase 1/Phase 2 | |
Terminated |
NCT00589953 -
High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study
|
Phase 2 | |
Completed |
NCT00120588 -
Neuroprotection by Magnesium Sulfate Given to Women at Risk of Very Preterm Birth
|
Phase 4 | |
Completed |
NCT04077333 -
MISA to NRDS:a Multicenter Study in China
|
N/A | |
Recruiting |
NCT03672877 -
Randomized Controlled Trial of Early Intensive Leg Exercise to Improve Walking in Children With Diplegia
|
N/A | |
Completed |
NCT00413946 -
Does Erythropoietin Improve Outcome in Very Preterm Infants?
|
Phase 2 | |
Terminated |
NCT00303082 -
Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
|
Phase 3 | |
Completed |
NCT02784821 -
Antibiotic "Dysbiosis" in Preterm Infants
|
Phase 2 | |
Completed |
NCT04535375 -
Sonographic QUantification of Venous Circulation In the Preterm Brain
|
N/A | |
Completed |
NCT00014989 -
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
|
Phase 3 | |
Withdrawn |
NCT03527498 -
Evaluation of Long-term Neurodevelopment in Neonatal Encephalopathy by Infant Treadmill
|
N/A | |
Terminated |
NCT03534466 -
Evaluation of Long-Term Gait Development in Infants With Neonatal Encephalopathy Using Infant Treadmill
|
N/A | |
Recruiting |
NCT05520359 -
Spinal Stimulation and Mobility Devices
|
N/A | |
Completed |
NCT02221219 -
Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury
|
Phase 1/Phase 2 | |
Recruiting |
NCT02814383 -
Prediction of Brain Injury in Premature Infants
|
||
Recruiting |
NCT03110341 -
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
|
Phase 3 |